Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr;120(4):932-952.
doi: 10.1002/bit.28309. Epub 2023 Jan 2.

"Toehold Switches; a foothold for Synthetic Biology"

Sai Sumanjali Yarra  1 , Ganapathy Ashok  1 , Utpal Mohan  1
Affiliations
Review

"Toehold Switches; a foothold for Synthetic Biology"

Sai Sumanjali Yarra et al. Biotechnol Bioeng. 2023 Apr.

Abstract

Toehold switches are de novo designed riboregulators that contain two RNA components interacting through linear-linear RNA interactions, regulating the gene expression. These are highly versatile, exhibit excellent orthogonality, wide dynamic range, and are highly programmable, so can be used for various applications in synthetic biology. In this review, we summarized and discussed the design characteristics and benefits of toehold switch riboregulators over conventional riboregulators. We also discussed applications and recent advancements of toehold switch riboregulators in various fields like gene editing, DNA nanotechnology, translational repression, and diagnostics (detection of microRNAs and some pathogens). Toehold switches, therefore, furnished advancement in synthetic biology applications in various fields with their prominent features.

Keywords: DNA nanotechnology; gene editing; gene expression; orthogonality; riboregulators; synthetic biology; toehold switches.

PubMed Disclaimer

References

REFERENCES

    1. Angenent-Mari, N. M., Garruss, A. S., Soenksen, L. R., Church, G., & Collins, J. J. (2020). A deep learning approach to programmable RNA switches. Nature Communications, 11, 5057. https://doi.org/10.1038/s41467-020-18677-1
    1. Bachellerie, J. P., Cavaillé, J., & Hüttenhofer, A. (2002). The expanding snoRNA world. Biochimie, 84, 775-790. https://doi.org/10.1016/s0300-9084(02)01402-5
    1. Bakhrebah, M. A., Nassar, M. S., Alsuabeyl, M. S., Zaher, W. A., & Meo, S. A. (2018). CRISPR technology: New paradigm to target the infectious disease pathogens. European Review for Medical and Pharmacological Sciences, 22, 3448-3452. https://doi.org/10.26355/eurrev_201806_15169
    1. Baliou, S., Adamaki, M., Kyriakopoulos, A. M., Spandidos, D. A., Panayiotidis, M., Christodoulou, I., & Zoumpourlis, V. (2018). CRISPR therapeutic tools for complex genetic disorders and cancer (review). International Journal of Oncology, 53, 443-468. https://doi.org/10.3892/ijo.2018.4434
    1. Balloux, F., & van Dorp, L. (2017). Q&A: What are pathogens, and what have they done to and for us? BMC Biology, 15, 91. https://doi.org/10.1186/s12915-017-0433-z

LinkOut - more resources